Each week on Saturday morning, the NeurologyLive® team puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.
FDA Clears High Dose Cohort of CTI-1601, SOMNUM AI Device Approved, Intracranial Pressure Monitoring and TBI
Neurology News Network for the week ending October 7, 2023. [WATCH TIME: 3 minutes]
AdComm Committee Downvotes NurOwn, ADELY01 Cleared for Trials, Axsome Pushes Back SYMPHONY Trial
Neurology News Network for the week ending September 30, 2023. [WATCH TIME: 4 minutes]
FDA Approves AIRAscore, Pimavanserin Packing Label Updated, Blarcamesine Data Released
Neurology News Network for the week ending September 23, 2023. [WATCH TIME: 3 minutes]
MS Treatments Linked With PML, Neflamapimod Effectiveness Based on P-Tau181 Levels, Nerivio Safe in Pregnant Women
Neurology News Network for the week ending September 16, 2023. [WATCH TIME: 3 minutes]
CNM-Au8 Improves Survival in ALS, New Parkinson Risk Factor Identified, Pamrevlumab Falls Short in Phase 3 Study
Neurology News Network for the week ending September 9, 2023. [WATCH TIME: 3 minutes]
Cell Therapy Bemdaneprocel Meets Primary Objective, Retinal Thickness in Parkinson Disease, TERIS Study Findings Published
Neurology News Network for the week ending September 2, 2023. [WATCH TIME: 3 minutes]
DT-216 Reduces Frataxin Levels in FA, Valbenazine FDA-Approved for Huntington Chorea, EU Approves Atogepant as Migraine Preventive
Neurology News Network for the week ending August 26, 2023. [WATCH TIME: 3 minutes]
FDA Approves DaxibotulinumtoxinA for Cervical Dystonia, Genetic Parkinson Trial Announced, DBS Improves Poststroke Mobility
Neurology News Network for the week ending August 19, 2023. [WATCH TIME: 4 minutes]
Vyvgart Hytrulo Meets Primary End Point, Trial on Fibromyalgia-Type Long COVID Continues, Aspirin Increased Intracranial Bleeding in Elders
Neurology News Network for the week ending August 12, 2023. [WATCH TIME: 3 minutes]
MS Medications Added to WHO Essential List, Epigenome Therapy Shows Efficacy in AD, Phase 3 NEURO-TTransform Results Announced
Neurology News Network for the week ending August 5, 2023. [WATCH TIME: 4 minutes]
Positive Data on Dravet Therapy STK-001, FDA Clears Zoom 88 LDP Support, MS Diagnostic Guidelines Updated
Neurology News Network for the week ending July 29, 2023. [WATCH TIME: 4 minutes]
TRAILBLAZER-ALZ-2 Data of Donanemab Published, Risdiplam Effective in SMA up to 4 Years, Preclinical Alzheimer Study of Lecanemab Announced
Neurology News Network for the week ending July 22, 2023. [WATCH TIME: 3 minutes]
Sleeping Pills and Increased Mortality, IPX203 Receives CRL, CT1812 Impacts Brain Function
Neurology News Network for the week ending July 8, 2023. [WATCH TIME: 3 minutes]
Gene Therapy AMT-130 in Huntington Disease, NDA Submitted for Troriluzole in Spinocerebellar Ataxia, FDA Clears Alzheimer Assays
Neurology News Network for the week ending July 1, 2023. [WATCH TIME: 3 minutes]
CNM-Au8 Reduces Neurofilament Light, Candesartan Benefits Headache, Ketamine Shows Potential in Migraine
Neurology News Network for the week ending June 24, 2023. [WATCH TIME: 3 minutes]
Phase 3 LAVENDER Trial Results Published, Protective and Risk Factors of Insomnia, Lecanemab Gets Positive FDA AdComm Review
Neurology News Network for the week ending June 17, 2023. [WATCH TIME: 3 minutes]
BIIB122 Discontinued in LRRK2 Parkinson Disease, Pimavanserin and PTSD-Associated Insomnia, Obstructive Sleep Apnea Following VNS
Neurology News Network for the week ending June 10, 2023. [WATCH TIME: 3 minutes]
CMS Adds Coverage for Antiamyloid Therapies, NDA for Migraine Agent Accepted, INTUNE Study Ahead of Schedule
Neurology News Network for the week ending June 2, 2023. [WATCH TIME: 3 minutes]
Wave Discontinues ALS Agent WVE-004, FDA Pushes Back Decision on SRP-9001, Asundexian Receives Fast Track Designation
Neurology News Network for the week ending May 27, 2023. [WATCH TIME: 3 minutes]
Treg Treatment Sustains Cognition in AD, FDA Approves Spinal Cord Stimulation Systems, Soticlestat Reduces Seizures in CDD
Neurology News Network for the week ending May 20, 2023. [WATCH TIME: 4 minutes]
CVD Risk in Epilepsy Increases Dementia Risk, Teriflunomide in RIS, FDA Clears Dry-Sensor EEG Headset
Neurology News Network for the week ending May 13, 2023. [WATCH TIME: 4 minutes]
Zavegepant Effective Regardless of Aura Status, FDA Approves Extended-Release Sodium Oxybate, Mediterranean Diet Adherence Improves MS Cognition
Neurology News Network for the week ending May 6, 2023. [WATCH TIME: 4 minutes]
Atogepant's Impact on Chronic Migraine, LD/CD Intra-Oral Pump Improves ON Time, Ravulizumab Effective in NMOSD Subgroups
Neurology News Network for the week ending April 30, 2023. [WATCH TIME: 4 minutes]
DEA Rules Fenfluramine No Longer Controlled Substance, Positive FDA ADComm Meeting of Brexpiprazole, Antiamyloid Drugs Accelerate Brain Atrophy
Neurology News Network for the week ending April 22, 2023. [WATCH TIME: 4 minutes]
EASEE Device Reduces Seizures in DRE, Narcolepsy Incidence Increased During H1N1 Pandemic, Trial of GTX-104 Moving Forward
Neurology News Network for the week ending April 15, 2023. [WATCH TIME: 4 minutes]
Remternetug Significantly Reduces Amyloid Plaque, Phase 3 INTUNE Study Accelerated, Pitolisant Approved for Pediatric Narcolepsy by EMA
Neurology News Network for the week ending April 8, 2023. [WATCH TIME: 4 minutes]
Lecanemab Adds Quality-Adjusted Life Years, FDA to Hold AdComm Meeting Over NurOwn, SYMBYX Neuro Improves PD Symptoms
Neurology News Network for the week ending April 1, 2023. [WATCH TIME: 4 minutes]
Efgartigimod Effective Across Subgroups, FDA to Hold AdComm Meeting on SRP-9001, Reboxetine Demonstrates Positive Effect on Obstructive Sleep Apnea
Neurology News Network for the week ending March 25, 2023. [WATCH TIME: 3 minutes]
Cognitive and Functional Differences in Parkinson, FDA Lifts Hold on IkT-148009, Solanezumab Shows No Impact on Cognitive Decline
Neurology News Network for the week ending March 18, 2023. [WATCH TIME: 4 minutes]
Efgartigimod Improves HR-Related Quality of Life, Traditional Approval for Lecanemab Pending, Satrlizumab Benefits NMOSD After Switching
Neurology News Network for the week ending March 11, 2023. [WATCH TIME: 3 minutes]